TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04749914

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lasmiditan
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lasmiditan
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabigatran Etexilate
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Administered orally.
Study: NCT06214403

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MET-2
Description: Microbial Ecosystem Therapeutics (MET) is a defined microbial community derived from healthy donor stool. MET capsules are orally administered mixtures of pure cultures of human-derived bacterial strains.
Study: NCT04511026

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indocyanine Green (ICG)
Description: Cyanine dye used in medical diagnostics manufactured by Akorn Inc.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neoprobe Gamma Detection System NPB11L(Model1102)
Description: Neoprobe Gamma Detection System NPB11L(Model1102) made by Devicor Medical Products, Inc.
Study: NCT06214403

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Microcrystalline Cellulose
Study: NCT04692389

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Jalosome soothing gel
Description: This study has not got other intervention
Study: NCT04273269

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: LYS-GM101
Description: LYS-GM101 is an adeno-associated viral vector serotype rh.10 (AAVrh.10) carrying the human β-galactosidase gene, formulated as a suspension for injection
Study: NCT05344911

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol combined with remifentanil
Description: Anesthesia induction: midazolam 0.02 mg/kg, propofol（TCI） 3 μ g/mL, remifentanil 1μ g/kg and rocuronium 0.6 mg/kg . Anesthesia maintenance: target-controlled infusion of propofol combined with remifentanil(0.1-0.3ug/kg/min)
Study: NCT04471311

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sub-lay mesh supported closure
Description: A 4 cm space is created between posterior rectus sheath and rectus muscle, widening 2 cm at each side of midline. Both posterior rectus sheath edges are sutured using a running slowly absorbable suture. Above the arcuate line, posterior layer is reinforced suturing the peritoneum and the posterior rectus sheath; below the arcuate line, the posterior layer is reinforced suturing the peritoneum and the trasversalis fascia. Anterior layer is re-established suturing the anterior rectus sheath. A 3 cm BIO-A Mesh strip is sutureless placed between the posterior rectus sheath and the rectus muscle with an overlap of 1,5 cm at each side. In laparotomies \>20 cm two stripes of 15 cm each is designed. The midline anterior rectus sheath is closed using a running slowly absorbable suture , covering the mesh.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BIO-A (GORE) mesh
Description: 3 cm BIO-A Mesh strip
Study: NCT06277440

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cognitive training
Description: cognitive training, 15 min, three times per week, for 12 weeks
Study: NCT05474105

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplement
Description: Daily drink 125 ml together with meal
Study: NCT05997836

Intervention type: OTHER
Group type: OTHER
Intervention: Implementation Facilitation
Description: Implementation Facilitation involves and External Facilitator (from outside of the participating medical center) and an Internal Facilitator (from inside the participating medical center) working together to help BHIP teams within the site adopt care practices that are more consistent with the CCM
Study: NCT06277440

Intervention type: OTHER
Group type: OTHER
Intervention: active control
Description: Traditional rehabilitation programs
Study: NCT05564637

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treprostinil
Description: 30mcg (5 breaths) of inhaled treprostinil will be administered during the RHC procedure and patients will be initiated on outpatient inhaled treprostinil therapy for 3-months with gradual up titration to target dose as per standard clinical practice.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Right Heart Catheterization (RHC) while exercising
Description: A procedure to measure how well or poorly your heart is pumping and to measure the pressures in the heart and lungs. A catheter will be inserted into a vein and artery in order to take the measurements and this will be conducted while exercising on a supine cycle ergometer. Various measurements will be taken during periods of rest and exercise.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Right Heart Catheterization (RHC) while exercising
Description: A procedure to measure how well or poorly your heart is pumping and to measure the pressures in the heart and lungs. A catheter will be inserted into a vein and artery in order to take the measurements and this will be conducted while exercising on a supine cycle ergometer. Various measurements will be taken during periods of rest and exercise.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Optional Muscle Biopsy
Description: A sample of muscle tissue will be collected and analyzed for the ability of the cells to utilize oxygen.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Optional Muscle Biopsy
Description: A sample of muscle tissue will be collected and analyzed for the ability of the cells to utilize oxygen.
Study: NCT06590181

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga Nidra
Description: This protocol is derived from The Origin and Clinical Relevance of Yoga Nidra (Pandi-Perumal, S. R. 2022)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Yoga Nidra with Pain Acceptance Intention
Description: Yoga Nidra with Pain Acceptance Intention

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Yoga Nidra with Pain Acceptance Intervention and Motor Imagery
Description: Yoga Nidra with Pain Acceptance Intervention and Motor Imagery
Study: NCT06656637

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Memory Drilling
Description: The experimental group will receive the additional intervention during their seven sessions with their care providers. The intervention is computerized memory drills training. This training includes the completion of a list learning memory task (HVLT) and then a PM practice task conducted on the computer at each session.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Compensatory Strategies
Description: Participants learn compensatory strategies to assist with their memory performance. This involves both external strategies, such as calendering and setting alarms, and internal strategies, like imagery and mnemonics.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Compensatory Strategies
Description: Participants learn compensatory strategies to assist with their memory performance. This involves both external strategies, such as calendering and setting alarms, and internal strategies, like imagery and mnemonics.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Compensatory Strategies
Description: Participants learn compensatory strategies to assist with their memory performance. This involves both external strategies, such as calendering and setting alarms, and internal strategies, like imagery and mnemonics.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Processing Therapy
Description: This is PTSD-targeted therapy.
Study: NCT06267417

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser therapy
Description: - Laser will be applied with the specified wave length using Diode laser (Sirrolaser Blue ™, USA) device over 5 consecutive days from start of chemotherapy cycle beside the standard preventive protocol applied in the hospital

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Mock treatment
Description: The exact repetition of the treatment modality but without any laser emission beside the standard preventive protocol applied in the hospital
Study: NCT06605209

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Peripheral Balloon-Expandable Covered Stent System
Description: The intervention in this clinical trial involves the Peripheral Balloon-Expandable Covered Stent System. This stent system is specifically designed for the treatment of stenosis and/or occlusion in the common and external iliac arteries.
Study: NCT04816266

Intervention type: DEVICE
Intervention: Iol master
Description: Iol master measures the distance between anterior pole of the cornea and the anterior surface of the lens to calculate the anterior chamber depth
Study: NCT06655740

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RF Vapor Ablation
Description: RF Vapor ablation of the duodenum
Study: NCT06308172

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hysterotomy closure
Description: Hysterotomy closure is done in either one of two ways. Single layer closure consists in a single layer, unlocked suture. Double layer closure consists in a double layer, unlocked suture.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hysterotomy closure
Description: Hysterotomy closure is done in either one of two ways. Single layer closure consists in a single layer, unlocked suture. Double layer closure consists in a double layer, unlocked suture.
Study: NCT04816266

Intervention type: DEVICE
Intervention: Iol master
Description: Iol master measures the distance between anterior pole of the cornea and the anterior surface of the lens to calculate the anterior chamber depth

Intervention type: DEVICE
Intervention: Pentacam
Description: The Pentacam HR calculates Anterior chamber depth from the corneal endothelial layer along a line from the apex of the cornea to the anterior surface of the lens

Intervention type: DEVICE
Intervention: Pentacam
Description: The Pentacam HR calculates Anterior chamber depth from the corneal endothelial layer along a line from the apex of the cornea to the anterior surface of the lens

Intervention type: DEVICE
Intervention: Pentacam
Description: The Pentacam HR calculates Anterior chamber depth from the corneal endothelial layer along a line from the apex of the cornea to the anterior surface of the lens
Study: NCT06159985

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: left posterior pericardiostomy
Description: In patients assigned to the study group, a 4-5 cm vertical incision posterior to the phrenic nerve and extending from the left inferior pulmonary vein to the diaphragm is performed.
Study: NCT05382520

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Questionares and practice
Description: Questionares and practice
Study: NCT06260020

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Comprehensive module for management of sleep disorders[Behavioral and pharmacological therapy]
Description: Development of module by Delphi method:components of Module include Behavioural intervention Modifying stimulus by change in location,using bedtime stories. Giving schedules to activities which interfere with sleep before bedtime. Using a bedtime pass to allow child to make a prefixed number of requests for parental attention while in bed.~Giving sleep items like cuddle toys to replace parental presence. Gradually delaying the bedtime so the child feels urge to sleep. Sleep hygiene by providing suitable environment to sleep, proper bedtime routine, sleep wake schedules Providing rewards for following good bedtime routine as positive reinforcement. Pharmacological intervention Sleep disorders due to underlying ENT, pulmonary conditions, to be treated as per standard protocol Usage of melatonin if required for sleep onset difficulty An 80%agreement over an intervention will be included in the module
Study: NCT06590675

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chlorhexidine Gluconate (CHG)
Description: A locally-prepared CHG formulation as a 1% or 2% solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chlorhexidine Gluconate (CHG)
Description: A locally-prepared CHG formulation as a 1% or 2% solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chlorhexidine Gluconate (CHG)
Description: A locally-prepared CHG formulation as a 1% or 2% solution
Study: NCT05223673

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Futuximab/modotuximab
Description: Concentrate for solution for infusion, futuximab/modotuximab will be administered via IV route, once weekly of each cycle at 9 mg/kg/dose at Cycle 1 Day 1 and then at 6 mg/kg/dose. Each cycle is up to 28 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trifluridine/Tipiracil
Description: Film-coated tablets of trifluridine/tipiracil (35 mg/m²/dose) will be administered orally before futuximab/ modotuximab administration, twice a day (BID) within 1 hour after completion of morning and evening meals, 5 days on/2 days off, over 14 days, followed by a 14-day rest. This treatment cycle will be repeated every 28 days.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trifluridine/Tipiracil
Description: Film-coated tablets of trifluridine/tipiracil (35 mg/m²/dose) will be administered orally twice a day (BID) within 1 hour after completion of morning and evening meals, 5 days on/2 days off, over 14 days, followed by a 14-day rest. This treatment cycle will be repeated every 28 days.
Study: NCT05938517

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Betahistine dihydrochloride
Description: Each subject received single dosages of Betahistine (24 mg, 48 mg, 96 mg) for pharmacokinetic serum draw with at least two days between the different dosages.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Betahistine dihydrochloride
Description: Each subject received single dosages of Betahistine (24 mg, 48 mg, 96 mg) for pharmacokinetic serum draw with at least two days between the different dosages.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selegiline-hydrochloride
Description: In the second period, each subject was pre-treated with Selegiline (5 mg/day) for one week and treated continuously with Selegiline (5 mg/day) in combination with the single dosages of Betahistine (24 mg, 48 mg, 96 mg) with at least two days between the different dosages.
Study: NCT06557083

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Polyvagal Breathing Exercises
Description: Breathing exercises provided include, square breathing, modified Qigong breathing, and three step breathing

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: No Intervention
Description: The control group will not perform any intervention.
Study: NCT04866719

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IOL implantation experimental
Description: Mono- or bilateral implantation of toric intraocular lenses PODEYE TORIC. If only one eye qualifies for toric lens implantation due to small amount of pre-existing corneal astigmatism, one eye will be implanted with PODEYE TORIC and the contralateral eye will be receive an implantation with the monofocal parent lens PODEYE (PhysIOL sa/nv, Liège, Belgium).
Study: NCT04576494

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Monthly assessments of functional motor abilities by a trained therapist
Description: Monthly assessments of functional motor abilities in adult 5q-SMA type 2 and type 3 patients by a trained therapist

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nusinersen
Description: nusinersen
Study: NCT06037564

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DOR/DTG/3TC
Description: Doravirine 100 mg (Pifeltro®) will be administered once daily in combination with co-formulated dolutegravir/lamivudine 50/300 mg (Dovato®) for a duration of 48 weeks.
Study: NCT06716619

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tumor Associated Lymph node T cell
Description: At least one lymph sample is resected from each participant, then it is separated and cultured ex vivo to expand the population of Tumor Associated Lymph node T cells . After lymphodepletion, patients are infused with TAL-T.
Study: NCT06060743

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: INS-MOBILE: Mobile Application Developed for Insulin Use
Description: After determining the application and control groups in the research, the purpose of the research was explained to both groups. Participants were informed that the application would last 1 month. It was explained that data collection forms would be filled out before the application (Z0), on the 14th day of the application (Z1), and on the 28th day of the application (Z2). On the 0th and 28th days of the follow-up, the participants' insulin administration skills were evaluated face-to-face by the researcher using the Insulin Therapy Skill Observation Form. In addition to the standard training given by diabetes training nurses, a mobile application on insulin use was sent to the application group, while the control group was given standard training only by diabetes training nurses.
Study: NCT04992598

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hypnosis session
Description: Hypnosis session will precede therapeutic strategies and reduction

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Reduction
Description: All dislocation would be reduced Under adequate analgesia and sufficient sedation. All methods for reduction can be used.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reduction
Description: All dislocation would be reduced Under adequate analgesia and sufficient sedation. All methods for reduction can be used.
Study: NCT05898113

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EXTRA VIRGIN OLIVE OIL
Description: Participants will consume a daily amount of extra virgin olive oil. Can consume the oil either raw or cooked

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EXTRA VIRGIN OLIVE OIL
Description: Participants will consume a daily amount of extra virgin olive oil. Can consume the oil either raw or cooked

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: OLIVE OIL LOW POLYPHENOL
Description: Participants will consume a daily amount of olive oil low polyphenol. Can consume the oil either raw or cooked

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: OLIVE OIL LOW POLYPHENOL
Description: Participants will consume a daily amount of olive oil low polyphenol. Can consume the oil either raw or cooked
Study: NCT05997836

Intervention type: OTHER
Group type: OTHER
Intervention: Implementation Facilitation
Description: Implementation Facilitation involves and External Facilitator (from outside of the participating medical center) and an Internal Facilitator (from inside the participating medical center) working together to help BHIP teams within the site adopt care practices that are more consistent with the CCM

Intervention type: OTHER
Group type: OTHER
Intervention: Implementation Facilitation
Description: Implementation Facilitation involves and External Facilitator (from outside of the participating medical center) and an Internal Facilitator (from inside the participating medical center) working together to help BHIP teams within the site adopt care practices that are more consistent with the CCM

Intervention type: OTHER
Group type: OTHER
Intervention: Implementation Facilitation
Description: Implementation Facilitation involves and External Facilitator (from outside of the participating medical center) and an Internal Facilitator (from inside the participating medical center) working together to help BHIP teams within the site adopt care practices that are more consistent with the CCM

Intervention type: OTHER
Group type: OTHER
Intervention: Centralized Technical Assistance
Description: Centralized Technical Assistance involves having external experts available for ad hoc consultation related to collaborative BHIP care practices.

Intervention type: OTHER
Group type: OTHER
Intervention: Centralized Technical Assistance
Description: Centralized Technical Assistance involves having external experts available for ad hoc consultation related to collaborative BHIP care practices.

Intervention type: OTHER
Group type: OTHER
Intervention: Centralized Technical Assistance
Description: Centralized Technical Assistance involves having external experts available for ad hoc consultation related to collaborative BHIP care practices.
Study: NCT06106555

Intervention type: BEHAVIORAL
Intervention: Dialectibal Behaviour Therapy
Description: Standard Dialectical Behaviour Therapy of up to 12 months as described Professor Linehan
Study: NCT06362499

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental Group
Description: After the initial assessment, all volunteers will receive a POWERbreathe® classic light resistance device (POWERbreathe®, Nsc, Brazil), to carry out the training, and will be individually guided on how to use it and how to complete the protocol. They will perform a trial session to familiarize themselves with the device that will not be considered for analysis. Every week, volunteers will receive a telephone call from researcher 2, who will not participate in the evaluation, to confirm whether the exercise with the POWERbreathe® will be performed appropriately at the recommended frequency, intensity, and duration and whether there are any questions regarding the protocol. At the end of each week, participants will receive a video call from researcher 2 to adjust the device according to G1's weekly load progression.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Experimental Group
Description: After the initial assessment, all volunteers will receive a POWERbreathe® classic light resistance device (POWERbreathe®, Nsc, Brazil), to carry out the training, and will be individually guided on how to use it and how to complete the protocol. They will perform a trial session to familiarize themselves with the device that will not be considered for analysis. Every week, volunteers will receive a telephone call from researcher 2, who will not participate in the evaluation, to confirm whether the exercise with the POWERbreathe® will be performed appropriately at the recommended frequency, intensity, and duration and whether there are any questions regarding the protocol. At the end of each week, participants will receive a video call from researcher 2 to adjust the device according to G1's weekly load progression.
Study: NCT06194175

Intervention type: PROCEDURE
Intervention: Bariatric surgery
Description: Participants whose application for bariatric surgery was accepted, regardless of the type of surgical intervention (e.g., sleeve gastrectomy, Roux-en-Y Gastric Bypass).~This longitudinal study includes five measurement times: before surgery and then, 6 months, one year, one and a half years and two years after surgery. At each measurement time, participants are asked to respond to a set of online questionnaires. Responses are anonymous.
Study: NCT05869487

Intervention type: RADIATION
Group type: OTHER
Intervention: Dual-energy X-ray absorptiometry
Description: Whole body x-ray absorptiometry
Study: NCT04564209

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Info Viz for Health
Description: During the intervention, health care providers provide HIV-related health education using a mobile app that contains a bilingual database of relevant infographics.